Why insider trading matters?
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
- Peter Lynch
Why insider trading matters?
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Organogenesis Holdings Inc., a regenerative medicine company, focuses on the development, manufacture, and commercialization of solutions for the advanced wound care, and surgical and sports medicine markets primarily in the United States. The company's pipeline products include TransCyte for the treatment of second- and third-degree burns; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; Novachor for the treatment of chronic and acute wounds; Gintuit for the treatment of mucogingival conditions in adults; and PuraPly XT and PuraPly MZ for the treatment of chronic and acute wounds, as well as for surgical treatment of open wounds. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician offices. The company sells its products through direct sales representatives and independent agencies.
| Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
|---|---|---|---|---|---|---|---|
| 2020-12-02 | MACKIE WAYNE D | Director | Buy | 38,710 | $5.26 | $203,615 | No |
| 2020-11-17 | MACKIE WAYNE D | Director | Buy | 42,726 | $3.25 | $138,860 | No |
| 2019-09-13 | MACKIE WAYNE D | Director | Buy | 4,990 | $6.13 | $30,570 | No |
| 2019-09-11 | MACKIE WAYNE D | Director | Buy | 13,010 | $5.30 | $69,017 | No |
| 2019-09-04 | MACKIE WAYNE D | Director | Buy | 82,000 | $4.47 | $366,211 | No |
Insider Smart
Insider Smart